Skip to content
Screener

Milestone Pharmaceuticals MIST Q2 2026 earnings

Reported August 12, 2026 · Before market open

Revenue$559.0KMiss by $257.7K
EPS-$0.21Miss by $0.01
Revenue estimate$816.7K
EPS estimate-$0.20

Next report

Nov 11, 2026 (in 2 months)
Revenue estimate$1.1M
EPS estimate-$0.20

FAQ

When did Milestone Pharmaceuticals report Q2 2026 earnings?
Milestone Pharmaceuticals (MIST) reported Q2 2026 earnings on August 12, 2026 before market open.
What were Milestone Pharmaceuticals's Q2 2026 revenue and EPS?
Milestone Pharmaceuticals reported revenue of $559.0K and eps of $-0.21 for Q2 2026.
Did Milestone Pharmaceuticals beat estimates in Q2 2026?
Revenue missed the consensus estimate of $816.7K by $257.7K. EPS missed the consensus estimate of $-0.20 by $0.01.
How did Milestone Pharmaceuticals's Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps declined 5.0% from $-0.20.
Where can I find Milestone Pharmaceuticals's Q2 2026 SEC filings?
You can read the 8-K earnings release (0001104659-26-094466) and the 10-Q periodic report (0001104659-26-094435) directly on SEC EDGAR. The filing index links above go to sec.gov.